Open AccessThe benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis
Author(s) -
Meral Kayıkçıoğlu,
Mevhibe Tümüklü,
Mehmet Özkahya,
Öner Özdoğan,
Gülay Aşçı,
Soner Duman,
Hüseyin Töz,
Levent Can,
Alı Başçı,
Ebru Sevinç Ok
Publication year - 2008
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfn599
Subject(s) - medicine , end stage renal disease , hemodialysis , kidney disease , retrospective cohort study , intensive care medicine , disease , end stage kidney disease , stage (stratigraphy) , fluid restriction , paleontology , biology , hyponatremia
Most haemodialysis (HD) centres use anti-hypertensive drugs for the management of hypertension, whereas some centres apply dietary salt restriction strategy. In this retrospective cross-sectional study, we assessed the effectiveness and cardiac consequences of these two strategies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom